The Roles of HyaluronanRHAMMCD44 and Their Respective Interactions along the Insidious Pathways of Fibrosarcoma Progression

Abstract EN

Fibrosarcomas are rare malignant mesenchymal tumors originating from fibroblasts.

Importantly, fibrosarcoma cells were shown to have a high content and turnover of extracellular matrix (ECM) components including hyaluronan (HA), proteoglycans, collagens, fibronectin, and laminin.

ECMs are complicated structures that surround and support cells within tissues.

During cancer progression, significant changes can be observed in the structural and mechanical properties of the ECM components.

Importantly, hyaluronan deposition is usually higher in malignant tumors as compared to benign tissues, predicting tumor progression in some tumor types.

Furthermore, activated stromal cells are able to produce tissue structure rich in hyaluronan in order to promote tumor growth.

Key biological roles of HA result from its interactions with its specific CD44 and RHAMM (receptor for HA-mediated motility) cell-surface receptors.

HA-receptor downstream signaling pathways regulate in turn cellular processes implicated in tumorigenesis.

Growth factors, including PDGF-BB, TGFβ2, and FGF-2, enhanced hyaluronan deposition to ECM and modulated HA-receptor expression in fibrosarcoma cells.

Indeed, FGF-2 through upregulation of specific HAS isoforms and hyaluronan synthesis regulated secretion and net hyaluronan deposition to the fibrosarcoma pericellular matrix modulating these cells’ migration capability.

In this paper we discuss the involvement of hyaluronan/RHAMM/CD44 mediated signaling in the insidious pathways of fibrosarcoma progression.